Legend Biotech CorpNASDAQ:LEGN
- LAST PRICE45.9100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots41.2100/ 3
- Ask / Lots46.6000/ 1
- Open / Previous Close0.0000 / 45.9100
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LEGN |
|---|---|---|
| 09:32 ET | 4058 | 45.07 |
| 09:34 ET | 700 | 44.975 |
| 09:36 ET | 575 | 44.73 |
| 09:38 ET | 3800 | 45.0206 |
| 09:39 ET | 10979 | 45.34 |
| 09:41 ET | 1140 | 45.48 |
| 09:43 ET | 700 | 45.3 |
| 09:45 ET | 1407 | 45.12 |
| 09:48 ET | 1880 | 44.745 |
| 09:50 ET | 2341 | 44.89 |
| 09:52 ET | 955 | 44.98 |
| 09:54 ET | 1700 | 44.735 |
| 09:56 ET | 2600 | 44.675 |
| 09:57 ET | 5896 | 44.39 |
| 09:59 ET | 4352 | 44.29 |
| 10:01 ET | 2997 | 44.52 |
| 10:03 ET | 651 | 44.3575 |
| 10:06 ET | 1051 | 44.35 |
| 10:08 ET | 660 | 44.49 |
| 10:10 ET | 814 | 44.51 |
| 10:12 ET | 1434 | 44.8 |
| 10:14 ET | 400 | 44.95 |
| 10:15 ET | 563 | 44.965 |
| 10:17 ET | 1200 | 45.13 |
| 10:19 ET | 5600 | 45.105 |
| 10:21 ET | 801 | 45.16 |
| 10:24 ET | 1050 | 45.32 |
| 10:26 ET | 1536 | 45.3014 |
| 10:28 ET | 1200 | 45.19 |
| 10:32 ET | 700 | 45.275 |
| 10:33 ET | 400 | 45.33 |
| 10:35 ET | 1400 | 45.39 |
| 10:37 ET | 1167 | 45.61 |
| 10:39 ET | 900 | 45.62 |
| 10:42 ET | 400 | 45.85 |
| 10:44 ET | 3376 | 45.685 |
| 10:46 ET | 300 | 45.68 |
| 10:48 ET | 2689 | 45.675 |
| 10:50 ET | 600 | 45.86 |
| 10:51 ET | 1400 | 45.77 |
| 10:53 ET | 4544 | 45.71 |
| 10:55 ET | 164 | 45.72 |
| 10:57 ET | 400 | 45.6 |
| 11:00 ET | 1500 | 45.71 |
| 11:02 ET | 700 | 45.69 |
| 11:04 ET | 558 | 45.72 |
| 11:06 ET | 3143 | 45.52 |
| 11:08 ET | 745 | 45.59 |
| 11:09 ET | 565 | 45.68 |
| 11:11 ET | 841 | 45.82 |
| 11:13 ET | 1400 | 45.97 |
| 11:15 ET | 824 | 46 |
| 11:18 ET | 4643 | 45.96 |
| 11:20 ET | 4662 | 46.08 |
| 11:22 ET | 2300 | 46.3 |
| 11:24 ET | 2205 | 46.295 |
| 11:26 ET | 1069 | 46.405 |
| 11:27 ET | 6176 | 46.48 |
| 11:29 ET | 3894 | 46.445 |
| 11:31 ET | 994 | 46.64 |
| 11:33 ET | 3749 | 46.43 |
| 11:36 ET | 1960 | 46.3 |
| 11:38 ET | 2380 | 46.22 |
| 11:40 ET | 1771 | 46.35 |
| 11:42 ET | 800 | 46.37 |
| 11:44 ET | 2122 | 46.18 |
| 11:45 ET | 900 | 46.23 |
| 11:47 ET | 2025 | 45.99 |
| 11:49 ET | 1048 | 46.04 |
| 11:51 ET | 700 | 46.12 |
| 11:54 ET | 800 | 46.2 |
| 11:56 ET | 741 | 46.17 |
| 11:58 ET | 900 | 46.12 |
| 12:00 ET | 1500 | 46 |
| 12:02 ET | 511 | 45.94 |
| 12:03 ET | 1133 | 46.04 |
| 12:05 ET | 900 | 46.07 |
| 12:07 ET | 1856 | 46.025 |
| 12:09 ET | 1100 | 46.19 |
| 12:12 ET | 1624 | 45.97 |
| 12:14 ET | 381 | 45.9 |
| 12:16 ET | 2100 | 46.15 |
| 12:18 ET | 500 | 46.18 |
| 12:20 ET | 1120 | 46.13 |
| 12:21 ET | 400 | 46.16 |
| 12:23 ET | 1354 | 46.16 |
| 12:25 ET | 900 | 46.15 |
| 12:27 ET | 1394 | 46.22 |
| 12:30 ET | 2170 | 46.155 |
| 12:32 ET | 758 | 46.21 |
| 12:34 ET | 1030 | 46.26 |
| 12:36 ET | 3206 | 46.345 |
| 12:38 ET | 7307 | 46.17 |
| 12:39 ET | 2398 | 46.14 |
| 12:41 ET | 1230 | 46.03 |
| 12:43 ET | 1100 | 46.005 |
| 12:45 ET | 2508 | 45.97 |
| 12:48 ET | 579 | 46.02 |
| 12:50 ET | 843 | 46.08 |
| 12:52 ET | 3915 | 46.065 |
| 12:54 ET | 7432 | 45.99 |
| 12:56 ET | 3979 | 45.96 |
| 12:57 ET | 14010 | 45.82 |
| 12:59 ET | 39962 | 45.91 |
Jul 3, 2024
DJ Legend Biotech Is Maintained at Outperform by BMO Capital, from 9:05AM ET on Wednesday Jul 03, 2024 by Dow Jones
9:05AM ET on Wednesday Jul 03, 2024 by Dow JonesDJ Legend Biotech Price Target Maintained With a $73.00/Share by HC Wainwright & Co., from 6:34AM ET on Wednesday Jul 03, 2024 by Dow Jones
6:34AM ET on Wednesday Jul 03, 2024 by Dow Jones
Jul 2, 2024
Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma, from 8:00AM ET on Tuesday Jul 02, 2024 by Dow Jones
8:00AM ET on Tuesday Jul 02, 2024 by Dow Jones
Jun 21, 2024
DJ Legend Biotech Price Target Maintained With a $86.00/Share by RBC Capital, from 10:34AM ET on Friday Jun 21, 2024 by Dow Jones
10:34AM ET on Friday Jun 21, 2024 by Dow Jones
Jun 17, 2024
DJ Legend Biotech Price Target Maintained With a $90.00/Share by Piper Sandler, from 1:22PM ET on Monday Jun 17, 2024 by Dow Jones
1:22PM ET on Monday Jun 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Legend Biotech Corp | 8.4B | -17.6x | --- |
Ascendis Pharma A/S | 7.8B | -14.0x | --- |
Blueprint Medicines Corp | 6.8B | -22.6x | --- |
Insmed Inc | 10.1B | -11.8x | --- |
Vaxcyte Inc | 8.3B | -18.1x | --- |
Intra-Cellular Therapies Inc | 7.3B | -59.9x | --- |
Company Information
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Contact Information
- Headquarters
- 2101 Cottontail LaneSOMERSET, NJ, United States 08873
- Phone
- 732-317-5050
- Fax
- ---
Executives
- Chairman of the Board
- Fangliang Zhang
- Chief Executive Officer, Director
- Ying Huang
- Chief Financial Officer
- Lori Macomber
- Director
- Ye Wang
- Director
- Li Zhu
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.4B |
|---|---|
Revenue (TTM) | $342.8M |
Shares Outstanding | 182.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.11 |
EPS | $-2.60 |
Book Value | $6.88 |
P/E Ratio | -17.6x |
Price/Sales (TTM) | 24.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -157.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
